SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-354184
Filing Date
2013-08-30
Accepted
2013-08-30 17:17:34
Documents
7
Period of Report
2013-08-28
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d591876d8k.htm 8-K 49419
2 EX-3.1 d591876dex31.htm EX-3.1 5592
3 EX-10.1 d591876dex101.htm EX-10.1 4633
4 EX-99.1 d591876dex991.htm EX-99.1 10928
5 EX-99.2 d591876dex992.htm EX-99.2 6119
6 GRAPHIC g591876g48b97.gif GRAPHIC 3386
7 GRAPHIC g591876img1.jpg GRAPHIC 29291
  Complete submission text file 0001193125-13-354184.txt   123527
Mailing Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137 305-575-6015
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 131073083
SIC: 2834 Pharmaceutical Preparations